These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 25490106)

  • 1. Challenges in managing HIV in people who use drugs.
    Kamarulzaman A; Altice FL
    Curr Opin Infect Dis; 2015 Feb; 28(1):10-6. PubMed ID: 25490106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
    Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP;
    Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention, treatment and care of hepatitis C virus infection among people who inject drugs.
    Bruggmann P; Grebely J
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S22-6. PubMed ID: 25245939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis and HIV in people who inject drugs: evidence for action for tuberculosis, HIV, prison and harm reduction services.
    Getahun H; Gunneberg C; Sculier D; Verster A; Raviglione M
    Curr Opin HIV AIDS; 2012 Jul; 7(4):345-53. PubMed ID: 22678489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV and hepatitis C treatment uptake among people who use drugs participating in the Amsterdam Cohort Studies, 1985-2015.
    van Santen DK; van der Helm JJ; Lindenburg K; Schim van der Loeff M; Prins M
    Int J Drug Policy; 2017 Sep; 47():95-101. PubMed ID: 28606392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reviewing harm reduction for people who inject drugs in Asia: the necessity for growth.
    Stone KA
    Harm Reduct J; 2015 Oct; 12():32. PubMed ID: 26472335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs.
    Altice FL; Kamarulzaman A; Soriano VV; Schechter M; Friedland GH
    Lancet; 2010 Jul; 376(9738):367-87. PubMed ID: 20650518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis, injecting drug use and integrated HIV-TB care: a review of the literature.
    Grenfell P; Baptista Leite R; Garfein R; de Lussigny S; Platt L; Rhodes T
    Drug Alcohol Depend; 2013 May; 129(3):180-209. PubMed ID: 23306095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV and viral hepatitis C coinfection in people who inject drugs: implications of new direct acting antivirals for hepatitis C virus treatment.
    Walsh N; Maher L
    Curr Opin HIV AIDS; 2012 Jul; 7(4):339-44. PubMed ID: 22498482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual, social, and structural factors affecting antiretroviral therapy adherence among HIV-positive people who inject drugs in Kazakhstan.
    Davis A; McCrimmon T; Dasgupta A; Gilbert L; Terlikbayeva A; Hunt T; Primbetova S; Wu E; Darisheva M; El-Bassel N
    Int J Drug Policy; 2018 Dec; 62():43-50. PubMed ID: 30359872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of HIV, viral hepatitis B/C and tuberculosis and treatment outcomes among people who use drugs: Results from the implementation of the first drop-in-center in Mozambique.
    Semá Baltazar C; Kellogg TA; Boothe M; Loarec A; de Abreu E; Condula M; Fazito E; Raymond HF; Temmerman M; Luchters S
    Int J Drug Policy; 2021 Apr; 90():103095. PubMed ID: 33429163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to highly active antiretroviral therapy impact on clinical and economic outcomes for Medicaid enrollees with human immunodeficiency virus and hepatitis C coinfection.
    Zhang S; Rust G; Cardarelli K; Felizzola J; Fransua M; Stringer HG
    AIDS Care; 2015; 27(7):829-35. PubMed ID: 25814041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential.
    Perlman DC; Jordan AE; Uuskula A; Huong DT; Masson CL; Schackman BR; Des Jarlais DC
    Int J Drug Policy; 2015 Nov; 26(11):1056-63. PubMed ID: 26050614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.
    Solomon SS; Mehta SH; Srikrishnan AK; Solomon S; McFall AM; Laeyendecker O; Celentano DD; Iqbal SH; Anand S; Vasudevan CK; Saravanan S; Lucas GM; Kumar MS; Sulkowski MS; Quinn TC
    Lancet Infect Dis; 2015 Jan; 15(1):36-45. PubMed ID: 25486851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost-effectiveness of harm reduction.
    Wilson DP; Donald B; Shattock AJ; Wilson D; Fraser-Hurt N
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S5-11. PubMed ID: 25727260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and risk factors associated with HIV and tuberculosis in people who use drugs in Abidjan, Ivory Coast.
    Bouscaillou J; Evanno J; Prouté M; Inwoley A; Kabran M; N'Guessan T; Djé-Bi S; Sidibé S; Thiam-Niangoin M; N'guessan BR; Blanchetière P; Luhmann N
    Int J Drug Policy; 2016 Apr; 30():116-23. PubMed ID: 26964902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
    Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
    Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "They don't like us….": Barriers to antiretroviral and opioid substitution therapy among homeless HIV positive people who inject drugs in Delhi: A mixed method study.
    Kumar S; Gupte HA; Isaakidis P; Mishra JK; Munjattu JF
    PLoS One; 2018; 13(8):e0203262. PubMed ID: 30161255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).
    Spire B; Lucas GM; Carrieri MP
    Int J Drug Policy; 2007 Aug; 18(4):262-70. PubMed ID: 17689374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards combination HIV prevention for injection drug users: addressing addictophobia, apathy and inattention.
    Strathdee SA; Shoptaw S; Dyer TP; Quan VM; Aramrattana A;
    Curr Opin HIV AIDS; 2012 Jul; 7(4):320-5. PubMed ID: 22498479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.